» Articles » PMID: 28962005

Association of Dynamic Changes in the CD4 T-Cell Transcriptome With Disease Severity During Primary Respiratory Syncytial Virus Infection in Young Infants

Overview
Journal J Infect Dis
Date 2017 Sep 30
PMID 28962005
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nearly all children are infected with respiratory syncytial virus (RSV) within the first 2 years of life, with a minority developing severe disease (1%-3% hospitalized). We hypothesized that an assessment of the adaptive immune system, using CD4+ T-lymphocyte transcriptomics, would identify gene expression correlates of disease severity.

Methods: Infants infected with RSV representing extremes of clinical severity were studied. Mild illness (n = 23) was defined as a respiratory rate (RR) < 55 and room air oxygen saturation (SaO2) ≥ 97%, and severe illness (n = 23) was defined as RR ≥ 65 and SaO2 ≤ 92%. RNA from fresh, sort-purified CD4+ T cells was assessed by RNA sequencing.

Results: Gestational age, age at illness onset, exposure to environmental tobacco smoke, bacterial colonization, and breastfeeding were associated (adjusted P < .05) with disease severity. RNA sequencing analysis reliably measured approximately 60% of the genome. Severity of RSV illness had the greatest effect size upon CD4 T-cell gene expression. Pathway analysis identified correlates of severity, including JAK/STAT, prolactin, and interleukin 9 signaling. We also identified genes and pathways associated with timing of symptoms and RSV group (A/B).

Conclusions: These data suggest fundamental changes in adaptive immune cell phenotypes may be associated with RSV clinical severity.

Citing Articles

Modeling Human Respiratory Syncytial Virus (RSV) Infection: Recent Contributions and Future Directions Using the Calf Model of Bovine RSV Disease.

Diaz F, McGill J J Immunol. 2023; 211(8):1180-1186.

PMID: 37782855 PMC: 10558079. DOI: 10.4049/jimmunol.2300260.


A systems genomics approach uncovers molecular associates of RSV severity.

McCall M, Chu C, Wang L, Benoodt L, Thakar J, Corbett A PLoS Comput Biol. 2021; 17(12):e1009617.

PMID: 34962914 PMC: 8746750. DOI: 10.1371/journal.pcbi.1009617.


Metatranscriptomics to characterize respiratory virome, microbiome, and host response directly from clinical samples.

Rajagopala S, Bakhoum N, Pakala S, Shilts M, Rosas-Salazar C, Mai A Cell Rep Methods. 2021; 1(6).

PMID: 34790908 PMC: 8594859. DOI: 10.1016/j.crmeth.2021.100091.


Airway gene-expression classifiers for respiratory syncytial virus (RSV) disease severity in infants.

Wang L, Chu C, McCall M, Slaunwhite C, Holden-Wiltse J, Corbett A BMC Med Genomics. 2021; 14(1):57.

PMID: 33632195 PMC: 7908785. DOI: 10.1186/s12920-021-00913-2.


Gene signature of children with severe respiratory syncytial virus infection.

Dapat C, Kumaki S, Sakurai H, Nishimura H, Labayo H, Okamoto M Pediatr Res. 2021; 89(7):1664-1672.

PMID: 33510411 PMC: 8249238. DOI: 10.1038/s41390-020-01347-9.


References
1.
Bont L, Heijnen C, Kavelaars A, van Aalderen W, Brus F, Draaisma J . Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur Respir J. 1999; 14(1):144-9. DOI: 10.1034/j.1399-3003.1999.14a24.x. View

2.
Bendelja K, Gagro A, Bace A, Krsulovic-Hresic V, Drazenovic V, Mlinaric-Galinovic G . Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin Exp Immunol. 2000; 121(2):332-8. PMC: 1905700. DOI: 10.1046/j.1365-2249.2000.01297.x. View

3.
Akhtar L, Benveniste E . Viral exploitation of host SOCS protein functions. J Virol. 2010; 85(5):1912-21. PMC: 3067810. DOI: 10.1128/JVI.01857-10. View

4.
Openshaw P, Chiu C . Protective and dysregulated T cell immunity in RSV infection. Curr Opin Virol. 2013; 3(4):468-74. PMC: 4295022. DOI: 10.1016/j.coviro.2013.05.005. View

5.
Egwuagu C, Yu C, Zhang M, Mahdi R, Kim S, Gery I . Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J Immunol. 2002; 168(7):3181-7. DOI: 10.4049/jimmunol.168.7.3181. View